Integrum AB

INTEG B

SE0009807266

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm 12:00:00 2026-09-14 EDT			5-day change	1st Jan Change
9.150 ^SEK	-0.54%		+1.67%	-14.96%

09-08	Integrum welcomes Ukraine pilot program for osseointegration	FW
09-08	Integrum Welcomes the Ukrainian Cabinet of Ministers' Decision to Introduce A State-Funded Pilot Program for Osseointegration	CI

Integrum - Q1 2026 Presentation

Published on 09/03/2026 at 07:21 am EDT

Finwire - Translated by Marketscreener - See original

Add MarketScreener to your sources

INTEGRUM AB

-0.54%

The medical technology company Integrum presented its first quarter report today, featuring CEO Martin Hillsten and CFO Louise Wahlin.

Link to the webcast: https://www.youtube.com/live/AFsyr5Wq-nU

Add MarketScreener to your sources

Latest news about Integrum AB

09-08	Integrum welcomes Ukraine pilot program for osseointegration	FW
09-08	Integrum Welcomes the Ukrainian Cabinet of Ministers' Decision to Introduce A State-Funded Pilot Program for Osseointegration	CI
09-03	Integrum - Q1 2026 Presentation	FW
09-03	Integrum AB Reports Earnings Results for the First Quarter Ended July 31, 2026	CI
09-03	Integrum increases revenue and operating profit	FW
09-03	Calendar Thursday, September 3	FW
09-02	Calendar: Thursday, September 3	FW
07-28	Integrum receives new customs refund from the US of SEK 3.3m	FW
07-08	Board member buys shares in Integrum for 455,000 kronor	FW
07-02	Integrum CEO buys 15,000 shares	FW
06-29	Integrum Moves Closer to State Pilot Program in Ukraine	FW
06-29	Integrum Announces Proposal Submission for Expanded Use of Osseointegration in Ukraine Healthcare	CI
06-16	Sweden's Integrum Gets Initial SEK2.6 Million US Customs Refund	MT
06-16	Integrum receives 2.6m kronor customs refund	FW
06-09	Affärsvärlden views Integrum subsidiary Afyri as a potential spin-off candidate	FW

Integrum AB is a Sweden-based company within healthcare sector. It provides systems for bone-anchored prostheses for individuals with amputations. The Companyâ€™s solutions comprise OPRA Implant System, neural prosthetics, phantom limb pain treatment and prosthetic components. The OPRA implant system is based on osseointegration, enabling the direct connection of an artificial limb to the skeleton. The neural prosthetics technology implies ability to directly connect bionic prostheses to the patientâ€™s bone, nerves, and muscles. A method for limb pain treatment implies motor execution of the phantom limb as a treatment, which is aided by machine learning, augmented and virtual reality. The Company provides a variety of prosthetic components required to connect the OPRA Implant System to external prostheses.

Employees

Sector

Medical Equipment, Supplies & Distribution

Calendar

12-02 Earnings release - Q2 2027

More about the company